Pre-Open Stock Movers 04/07: (SOS) (NMTR) (UTME) Higher; (FGEN) (GEO) (FIXX) Lower (more...)
- S&P 500, Dow climb for third day and close at records
- Tesla (TSLA) China Numbers 'Robust' - Wedbush
- Apple (AAPL) Shares Seen as 'Attractive' as Recent Checks Show Continuously Strong Demand - Citi
- Investors Poured More Money Into Stocks in Past 5 Months Than Last 12 Years, Says BofA, Analysts Worried About Stretched Valuations
- Amazon.com warehouse workers vote to reject forming union in Alabama
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Today's Pre-Open Movers
SOS Limited (NYSE: SOS) 30.7% HIGHER; sees heavy social media activity
FibroGen, Inc. (Nasdaq: FGEN) 29.2% LOWER; provided clarification of certain prior disclosures of U.S. primary cardiovascular safety analyses from the roxadustat Phase 3 program for the treatment of anemia of chronic kidney disease (CKD).
The GEO Group, Inc. (NYSE: GEO) 15.4% LOWER; announced today that its Board of Directors (the “Board”) has immediately suspended GEO’s quarterly dividend payments with the goal of maximizing the use of cash flows to repay debt, deleverage, and internally fund growth. GEO currently intends to maintain its corporate tax structure as a Real Estate Investment Trust (“REIT”), but the Board has determined to undertake an evaluation of GEO's structure as a REIT.
9 Meters Biopharma (NASDAQ: NMTR) 15.3% HIGHER; CEO acquired 100,000 shares and its CFO acquired 50,000, according to filings.
UTime Limited Ordinary Shares (NASDAQ: UTME) 11.5% HIGHER; adds to gains after jumping 875% in IPO debut.
Homology Medicines, Inc. (Nasdaq: FIXX) 10.2% LOWER; intends to offer and sell, subject to market and other conditions, $50.0 million of its common stock in an underwritten public offering. Homology expects to grant the underwriter a 30-day option to purchase up to an additional $7.5 million of its common stock. All of the shares in the proposed offering are to be sold by Homology.
TransMedics Group, Inc. (Nasdaq: TMDX) 10% HIGHER; announced that after the review of TransMedics' clinical evidence from the OCS Heart EXPAND trial, the associated Continued Access Protocol results, as well as the OCS Heart PROCEED II trial, the Circulatory Systems Device Advisory Panel convened by the U.S. Food and Drug Administration ("FDA") has issued a favorable vote in support of approval of the OCS Heart System to the FDA's Office of Health Technology 2 (Cardiovascular Devices). The panel voted 12 to 5, with 1 abstaining, that the benefits of the OCS Heart System outweigh its risks. The panel voted 10 to 6, with 2 abstaining, that there is reasonable assurance that the OCS Heart System is effective. The panel voted 9 to 7, with 2 abstaining, that there is reasonable assurance of the OCS Heart System's safety.
Ouster Inc. (NYSE: OUST) 9.6% HIGHER; Citi initiates coverage with a Buy rating and a price target of $17.00.
Altimeter (NASDAQ: AGC) 9.2% HIGHER; Grab Could Finalize Agreement to List Through AGC SPAC as Soon as This Week - FT
XL Fleet Corp. (NYSE: XL) 7.7% HIGHER; XL and Apex Clean Energy (Apex), a leading clean energy company that develops, constructs, and operates utility-scale wind and solar power facilities throughout North America, today announced that XL Fleet is electrifying Apexs vehicle fleet as part of a comprehensive effort to reduce its carbon emissions.
National CineMedia (NASDAQ: NCMI) 7.3% HIGHER; Benchmark upgraded from Hold to Buy with a price target of $6.00.
Phreesia, Inc. (NYSE: PHR) 6.7% LOWER; commenced an underwritten public offering of 4,500,000 shares of its common stock, to be offered by the Company.
CA Healthcare Acquisition Corp (Nasdaq: CAHC) 6.7% HIGHER; announced a definitive merger agreement with LumiraDx Limited (LumiraDx) a next-generation point of care (POC) diagnostics testing company. The combination reflects a value of $5.0 billion for Lumiras existing equity, before giving effect to the transaction. Since its founding, LumiraDx has raised $700 million in equity capital including investments by Morningside Ventures, U.S. Boston Capital Corporation, The Bill & Melinda Gates Foundation, Petrichor Healthcare Capital Management and other global strategic partners.
Oncternal Therapeutics (NASDAQ: ONCT) 6.4% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $14.00.
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) 5.8% LOWER; announced today that it intends to offer, subject to market conditions and other factors, $500.0 million aggregate principal amount of Convertible Senior Notes due 2026 (the "notes") in a private placement (the "offering") to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Ionis also intends to grant the initial purchasers of the notes an option to purchase, within the 13-day period beginning on, and including, the first date on which the notes are issued, up to an additional $75.0 million principal amount of notes.
Vertex Inc. (NASDAQ: VERX) 5% LOWER; Morgan Stanley downgraded from Equalweight to Underweight with a price target of $18.00 (from $22.00).
Genworth Financial, Inc. (NYSE: GNW) 4.6% LOWER; exercised its right to terminate its merger agreement with China Oceanwide Holdings Group Co., Ltd. (Oceanwide) as of April 6, 2021. Terminating the agreement allows Genworth to pursue its revised strategic plan without restrictions and without uncertainty regarding its ultimate ownership, which might impact the Company's ability to successfully execute the plan.
Outset Medical, Inc. (Nasdaq: OM) 4.5% LOWER; announced today the commencement of a proposed underwritten public offering of 2,500,000 shares of its common stock by Outset and 2,500,000 shares of its common stock by certain of its stockholders. I
Norwegian Cruise Line (NYSE: NCLH) 2.6% HIGHER; CDC said cruises could resume by mid-summer with restrictions, according to Bloomberg, citing an email.
Royal Caribbean Group (NYSE: RCL) 2.4% HIGHER; CDC said cruises could resume by mid-summer with restrictions, according to Bloomberg, citing an email.
Carnival Corp. (NYSE: CCL) 2.1% HIGHER; CDC said cruises could resume by mid-summer with restrictions, according to Bloomberg, citing an email.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grab is said to announce deal with Altimeter Growth Corp (AGC) next week - Bloomberg
- Global SPAC Partners (GLPS) IPO Prices at $10
- After-Hours Stock Movers 04/07: (AVCT) (SBBP) (CARG) Higher; (OTIC) (LNDC) (ASO) Lower (more...)
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesCiti, Morgan Stanley, Standard & Poor's, Bill & Melinda Gates Foundation Trust, Pre-Open Losers, Pre-Open Winners, Definitive Agreement, IPO, Pre Market Movers, FDA, SPAC
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!